CELERY PLUS ANISE VERSUS METFORMIN FOR TREATMENT OF OLIGOMENORRHEAIN POLYCYSTIC OVARY SYNDROME: A TRIPLE-BLIND, RANDOMIZED CLINICALTRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Moini Jazani Arezoo; NAZEMIYEH HOSSEIN; TANSAZ MOJGAN; SADEGHI BAZARGANI HOMAYOUN; FAZLJOU SEYED MOHAMMAD BAGHER; Nasimi Doost Azgomi Ramin; HAMDI KOBRA

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Iranian Red Crescent Medical Journal Year:2018 | Volume:20 | Issue:5 Page(s): 0-0

Download Full-Text

View:

803

Download:

468

Cites:

Information Journal Paper

Title

CELERY PLUS ANISE VERSUS METFORMIN FOR TREATMENT OF OLIGOMENORRHEAIN POLYCYSTIC OVARY SYNDROME: A TRIPLE-BLIND, RANDOMIZED CLINICALTRIAL

Author(s)

Keywords

MEDICINE

METFORMIN

OLIGOMENORRHEA

POLYCYSTIC OVARY SYNDROME

TRADITIONAL

APIUM GRAVEOLENS

PIMPINELLA ANISUM

Abstract

Background: POLYCYSTIC OVARY SYNDROME (PCOS)-induced OLIGOMENORRHEA can leave psychological and non-psychological impactson women. Among the proposed strategies for its treatment, herbal medications are of importance due to favorable effect profiles. Objectives: We planned a study to compare the effects of Celery and Anise combination (CAC) and METFORMIN (met. ) on OLIGOMENORRHEAin PCOS patients. Methods: We conducted a triple-blind, Randomized clinical trial on 72 patients that were randomly allocated into two equal groupsto receive six capsules of either CAC (750mgeach) or met. (250mgeach) at three separate doses for 15 days beginning from the follicularphase. If the bleeding occurred, three capsules of either placebo or met. would be administered daily during the menstruationphase, and then the follicular phase step with six capsules would be repeated. If the bleeding did not occur, three capsules of eitherplacebo or met. would be administered each day for 15 days. The regularity of menstrual bleeding as the primary outcome, as wellas testosterone, luteinizing hormone/follicular stimulating hormone ratio (LH/FSH), and complications, was assessed before andafter the three cycles. Results: The mean age standard deviation of patients was 26. 5 6. 1. The mean Body Mass Index was 26. 4 3. 5. CAC significantlyimproved OLIGOMENORRHEA (58. 3% vs. 25%, P < 0. 01), increased bleeding episodes (P = 0. 003), and reduced testosterone (mean difference: 0. 16 vs.-0. 02, P = 0. 005) and LH/FSH (mean difference: 0. 75 vs.-0. 08, P = 0. 002) without any major side effects compared tomet. Conclusions: We showed that Celery and Anise combination could regulate menstrual cycles and improve OLIGOMENORRHEA in polycysticovary syndrome patients superiorly to METFORMIN.

Cites

No record.

References

Cite

APA: Copy

Moini Jazani, Arezoo, NAZEMIYEH, HOSSEIN, TANSAZ, MOJGAN, SADEGHI BAZARGANI, HOMAYOUN, FAZLJOU, SEYED MOHAMMAD BAGHER, Nasimi Doost Azgomi, Ramin, & HAMDI, KOBRA. (2018). CELERY PLUS ANISE VERSUS METFORMIN FOR TREATMENT OF OLIGOMENORRHEAIN POLYCYSTIC OVARY SYNDROME: A TRIPLE-BLIND, RANDOMIZED CLINICALTRIAL. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), 20(5), 0-0. SID. https://sid.ir/paper/293743/en

Vancouver: Copy

Moini Jazani Arezoo, NAZEMIYEH HOSSEIN, TANSAZ MOJGAN, SADEGHI BAZARGANI HOMAYOUN, FAZLJOU SEYED MOHAMMAD BAGHER, Nasimi Doost Azgomi Ramin, HAMDI KOBRA. CELERY PLUS ANISE VERSUS METFORMIN FOR TREATMENT OF OLIGOMENORRHEAIN POLYCYSTIC OVARY SYNDROME: A TRIPLE-BLIND, RANDOMIZED CLINICALTRIAL. IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ)[Internet]. 2018;20(5):0-0. Available from: https://sid.ir/paper/293743/en

IEEE: Copy

Arezoo Moini Jazani, HOSSEIN NAZEMIYEH, MOJGAN TANSAZ, HOMAYOUN SADEGHI BAZARGANI, SEYED MOHAMMAD BAGHER FAZLJOU, Ramin Nasimi Doost Azgomi, and KOBRA HAMDI, “CELERY PLUS ANISE VERSUS METFORMIN FOR TREATMENT OF OLIGOMENORRHEAIN POLYCYSTIC OVARY SYNDROME: A TRIPLE-BLIND, RANDOMIZED CLINICALTRIAL,” IRANIAN RED CRESCENT MEDICAL JOURNAL (IRCMJ), vol. 20, no. 5, pp. 0–0, 2018, [Online]. Available: https://sid.ir/paper/293743/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops